Abstract Background Clinical outcome assessments (COAs) are key to patient‐centered
evaluation of novel interventions and supportive care. COAs are particularly informative in …

Purpose We investigated the prognostic value of pretreatment patient‐reported outcomes
(PROs) in patients with diffuse large B‐cell lymphoma (DLBCL) receiving obinutuzumab …

Improvements in chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), and
multiple myeloma (MM) treatment options have increased the 5-year survival rates for …

PURPOSE Social integration and relationship issues have been understudied among
adolescent and young adult (AYA) cancer survivors. This study compared social …

For many patients, the cancer continuum includes a syndrome known as cancer-associated
cachexia (CAC), which encompasses the unintended loss of body weight and muscle mass …

Purpose Identifying factors associated with treatment alteration (treatment discontinuation
and dose reduction) may help to attain the treatment goals for metastatic breast cancer. The …

Background Standardized, high-quality PRO data reporting is crucial for patient centered
care in the field of oncology, especially in clinical trials that establish standard of care. This …

Background Patient-reported outcome (PRO) measures are increasingly being implemented
in routine care to aid in clinical decision-making. However, the prognostic value of PRO …

Purpose The present study aimed to investigate the status and significantly influencing
factors of treatment and prognosis perceptions among advanced cancer patients based on …

Patient-reported outcomes (PROs) have considerable value for survival prediction, and
generally include both quality of life (QOL) and symptom measures. A recent metaanalysis of …